checkAd
    Startseite > Aktien > United Therapeutics > Nachrichten
    United Therapeutics Aktie
    245,40
     
    EUR
    -0,49 %
    -1,20 EUR
    Letzter Kurs 10.05.24 Tradegate
    243,20
     
    EUR
    20 STK
    Geldkurs 10.05.24
    247,70
     
    EUR
    20 STK
    Briefkurs 10.05.24
    ISIN: US91307C1027 · WKN: 923818 · SYM: UTH · USA

    Neueste Nachrichten

    United Therapeutics Corporation Reports First Quarter 2024 Financial Results
    01.05.24 · Business Wire (engl.) · United Therapeutics
    United Therapeutics Announces World’s First Successful Xenothymokidney Transplant
    24.04.24 · Business Wire (engl.) · United Therapeutics
    United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024
    24.04.24 · Business Wire (engl.) · United Therapeutics
    United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference
    16.04.24 · Business Wire (engl.) · United Therapeutics
    United Therapeutics Announces the First Comprehensive Review Publication on Xenotransplantation
    26.03.24 · Business Wire (engl.) · United Therapeutics
    United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program
    25.03.24 · Business Wire (engl.) · United Therapeutics
    United Therapeutics Corporation to Present at the Leerink Partners Global Biopharma Conference 2024
    05.03.24 · Business Wire (engl.) · United Therapeutics
    United Therapeutics Corporation to Present at the TD Cowen 44th Annual Health Care Conference
    27.02.24 · Business Wire (engl.) · United Therapeutics
    Fokus Aktien mit extremen Handelsvolumen am Mittwoch, den 21.02.2024
    21.02.24 · wO Chartvergleich · Deutsche Boerse
    United Therapeutics Corporation Reports Fourth Quarter and Full Year 2023 Financial Results
    21.02.24 · Business Wire (engl.) · United Therapeutics
    United Therapeutics Commences Litigation to Ensure Fairness in the Drug Review Process
    21.02.24 · Business Wire (engl.) · United Therapeutics
    United Therapeutics Corporation to Report Fourth Quarter and Full Year 2023 Financial Results Before the Market Opens on Wednesday, February 21, 2024
    14.02.24 · Business Wire (engl.) · United Therapeutics